Cartesian Therapeutics (RNAC) Return on Equity [ROE] (2016 - 2023)
Cartesian Therapeutics (RNAC) posted Return on Equity [ROE] of -61.96% for Q3 2023, down 93.79 percentage points from 31.84% a year earlier and down 7.89 percentage points from the prior quarter.
Powered by 
Analysis
Cartesian Therapeutics (RNAC) Return on Equity [ROE] (2016 - 2023) Analysis & Trends
For FY2022, Cartesian Therapeutics' Return on Equity [ROE] came in at 60.82%, up 1198.67 percentage points from FY2021.
- Annual Return on Equity [ROE] shows a five-year change of +181.40 percentage points (FY2017 to FY2022).
- In prior years, Cartesian Therapeutics' Return on Equity [ROE] was -1137.85% in FY2021, -3716.01% in FY2019 (-3433.81 pp) and -282.21% in FY2018 (-161.62 pp).
- The Q3 2023 figure stands as the lowest quarterly Return on Equity [ROE] since Q4 2021.
- On a year-over-year basis, Return on Equity [ROE] has declined in each of the last three quarters, with an average year-over-year change of +139.83 percentage points over the last four quarters.
- The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was Q4 2019, with a gain of 3547.13 percentage points; the weakest was Q4 2018, with a drop of 6489.25 percentage points.
- According to Business Quant data, Return on Equity [ROE] for the three prior quarters was -54.07% (Q2 2023), -7.73% (Q1 2023) and 23.98% (Q4 2022).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 22.24% |
| 10 | Cartesian Therapeutics | 216.57 Mn | 216.57 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2023 | -61.96% |
| Jun 30, 2023 | -54.07% |
| Mar 31, 2023 | -7.73% |
| Dec 31, 2022 | 23.98% |
| Sep 30, 2022 | 31.84% |
| Jun 30, 2022 | 24.46% |
| Mar 31, 2022 | 10.68% |
| Dec 31, 2021 | -726.07% |
| Dec 31, 2019 | -3,052.27% |
| Jun 30, 2019 | -794.18% |
| Mar 31, 2019 | -1,309.78% |
| Dec 31, 2018 | -6,599.40% |
| Sep 30, 2018 | -482.98% |
| Jun 30, 2018 | -224.64% |
| Mar 31, 2018 | -143.79% |
| Dec 31, 2017 | -110.14% |
| Sep 30, 2017 | -82.43% |
| Jun 30, 2017 | -88.48% |
| Mar 31, 2017 | -90.41% |
| Dec 31, 2016 | -59.28% |
API Access
Cartesian Therapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=RNAC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "RNAC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=RNAC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();